Critical Limb Ischemia
211
23
27
107
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
29 trials with published results (14%)
Research Maturity
107 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.6%
16 terminated out of 211 trials
87.0%
+0.4% vs benchmark
11%
23 trials in Phase 3/4
27%
29 of 107 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 107 completed trials
Clinical Trials (211)
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
Trial to Assess Chelation Therapy in Critical Limb Ischemia
Nutrition in Patient With Critical Limb Ischemia
MOTIV BTK Randomized Controlled Trial
Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage
FAZA PET/MRI in CLI Patients Pre and Post Revascularization
Heat Therapy for Peripheral Arterial Disease (HEATPAD)
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Single Versus Multiple Vessels Endovascular Tibial Arteries Revascularization for Critical Limb Ischemia
Percutaneous Deep Vein Arterialization Post-Market Study
PROMISE International
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Safety Study of Gene Therapy in Treating Critical Leg Ischemia
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes